OptiBiotix Health Plc (OPTI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, OptiBiotix Health Plc (OPTI) has a cash flow conversion efficiency ratio of -0.106x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-895.00K ≈ $-108.90 USD) by net assets (GBX8.42 Million ≈ $1.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OPTI net asset quality score to measure how much of total assets are equity-financed.
OptiBiotix Health Plc - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how OptiBiotix Health Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OptiBiotix Health Plc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
OptiBiotix Health Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of OptiBiotix Health Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Light Science Technologies Holdings PLC
LSE:LST
|
0.155x |
|
Sutton Harbour Holdings plc
LSE:SUH
|
-0.042x |
|
ECR Minerals plc
LSE:ECR
|
0.041x |
|
Conroy Gold & Natural Resources Plc
LSE:CGNR
|
-0.028x |
|
Aeorema Communications Plc
LSE:AEO
|
1.017x |
|
Kasikornbank Public Company Limited
F:TFBF
|
0.144x |
|
GREENBANK CAPITAL
F:2TL
|
N/A |
|
Premier African Minerals Ltd
LSE:PREM
|
-0.001x |
Annual Cash Flow Conversion Efficiency for OptiBiotix Health Plc (2008–2024)
The table below shows the annual cash flow conversion efficiency of OptiBiotix Health Plc from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of OptiBiotix Health Plc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX8.40 Million ≈ $1.02K |
GBX-1.77 Million ≈ $-215.11 |
-0.211x | -22.32% |
| 2023-12-31 | GBX8.87 Million ≈ $1.08K |
GBX-1.53 Million ≈ $-185.79 |
-0.172x | -69.24% |
| 2022-12-31 | GBX10.90 Million ≈ $1.33K |
GBX-1.11 Million ≈ $-134.93 |
-0.102x | -18.11% |
| 2021-12-31 | GBX18.17 Million ≈ $2.21K |
GBX-1.56 Million ≈ $-190.37 |
-0.086x | -9.96% |
| 2020-12-31 | GBX11.85 Million ≈ $1.44K |
GBX-927.96K ≈ $-112.91 |
-0.078x | +77.37% |
| 2019-12-31 | GBX4.98 Million ≈ $606.08 |
GBX-1.72 Million ≈ $-209.67 |
-0.346x | -98.06% |
| 2018-11-30 | GBX7.06 Million ≈ $859.29 |
GBX-1.23 Million ≈ $-150.09 |
-0.175x | +29.81% |
| 2017-11-30 | GBX7.05 Million ≈ $857.26 |
GBX-1.75 Million ≈ $-213.32 |
-0.249x | +0.09% |
| 2016-11-30 | GBX5.00 Million ≈ $608.74 |
GBX-1.25 Million ≈ $-151.61 |
-0.249x | +3.34% |
| 2015-11-30 | GBX3.82 Million ≈ $464.39 |
GBX-983.46K ≈ $-119.66 |
-0.258x | -69.62% |
| 2014-11-30 | GBX4.65 Million ≈ $565.66 |
GBX-706.24K ≈ $-85.93 |
-0.152x | +95.33% |
| 2013-11-30 | GBX115.88K ≈ $14.10 |
GBX-376.79K ≈ $-45.84 |
-3.251x | -33.04% |
| 2012-07-31 | GBX440.35K ≈ $53.58 |
GBX-1.08 Million ≈ $-130.94 |
-2.444x | -4398.03% |
| 2010-07-31 | GBX773.00K ≈ $94.05 |
GBX-42.00K ≈ $-5.11 |
-0.054x | +32.29% |
| 2009-07-31 | GBX810.00K ≈ $98.55 |
GBX-65.00K ≈ $-7.91 |
-0.080x | -145.20% |
| 2008-07-31 | GBX825.00K ≈ $100.38 |
GBX-27.00K ≈ $-3.29 |
-0.033x | -- |
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more